Factors affecting use of magnesium sulphate for pre‐eclampsia or eclampsia: a qualitative evidence synthesis

BACKGROUND: Hypertensive disorders account for 14% of global maternal deaths. Magnesium sulphate (MgSO(4)) is recommended for prevention and treatment of pre‐eclampsia/eclampsia. However, MgSO(4) remains underused, particularly in low‐ and middle‐income countries (LMICs). OBJECTIVE: This qualitative...

Descripción completa

Detalles Bibliográficos
Autores principales: Eddy, KE, Vogel, JP, Zahroh, RI, Bohren, MA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Systematic Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291451/
https://www.ncbi.nlm.nih.gov/pubmed/34520111
http://dx.doi.org/10.1111/1471-0528.16913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291451/
https://www.ncbi.nlm.nih.gov/pubmed/34520111
http://dx.doi.org/10.1111/1471-0528.16913

Ejemplares similares